LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 57

Search options

  1. Article ; Online: The impact of the 2022 spring COVID-19 booster vaccination programme on hospital occupancy in England: An interrupted time series analysis.

    Jain, Vageesh / Kerr, Gabriele / Beaney, Thomas

    PLOS global public health

    2024  Volume 4, Issue 3, Page(s) e0002046

    Abstract: Regular booster vaccination programmes help protect the most vulnerable from COVID-19 and limit pressure on health systems. Existing studies find booster doses to be effective in preventing hospital admissions and deaths but focus on individual effects, ... ...

    Abstract Regular booster vaccination programmes help protect the most vulnerable from COVID-19 and limit pressure on health systems. Existing studies find booster doses to be effective in preventing hospital admissions and deaths but focus on individual effects, failing to consider the population impact of incomplete vaccination coverage and seasonal patterns in disease transmission. We estimated the effectiveness of the 2022 spring booster vaccination programme, available for those aged 75 years and older, residents in care homes, and adults with weakened immune systems, on COVID-19 hospital bed occupancy in England. Booster vaccine coverage in the eligible population increased rapidly in the months after rollout (from 21st March 2022), flattening out just below 80% by July 2022. We used interrupted time series analysis to estimate a 23.7% overall reduction in the rate of hospital occupancy for COVID-19 following the programme, with a statistically significant benefit in the 6-12 weeks following rollout. In the absence of the programme, we calculate that a total of 380,104 additional hospital bed-days would have been occupied by patients with COVID-19 from 4th April to 31st August 2022 (95% CI: -122,842 to 1,034,590). The programme delayed and shortened the duration of the peak while not reducing its magnitude. In sensitivity analyses adjusting the start of the post-intervention period or removing the rate of COVID-19 infection in the over 60s from the model, the effect of the spring booster programme on hospital bed occupancy remained similar. Our findings suggest that timing is a critical consideration in the implementation of COVID-19 booster programmes and that policymakers cannot rely on intermittent booster vaccination of high-risk groups alone to mitigate anticipated peaks in hospital pressure due to COVID-19 epidemics.
    Language English
    Publishing date 2024-03-06
    Publishing country United States
    Document type Journal Article
    ISSN 2767-3375
    ISSN (online) 2767-3375
    DOI 10.1371/journal.pgph.0002046
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Re-evaluating national screening for chronic kidney disease in the UK.

    Jain, Vageesh / Sinha, Smeeta / Shaw, Catriona / Bramham, Kate / Croucher, Catherine

    BMJ (Clinical research ed.)

    2023  Volume 382, Page(s) e074265

    Language English
    Publishing date 2023-07-31
    Publishing country England
    Document type Journal Article
    ZDB-ID 1362901-3
    ISSN 1756-1833 ; 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    ISSN (online) 1756-1833
    ISSN 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    DOI 10.1136/bmj-2022-074265
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Financing global health emergency response: outbreaks, not agencies.

    Jain, Vageesh

    Journal of public health policy

    2019  Volume 41, Issue 2, Page(s) 196–205

    Abstract: Effectively responding to global health emergencies requires substantial financial commitment from many stakeholders, including governments, multilateral agencies, and nongovernmental organizations. A major current policy challenge needs attention: how ... ...

    Abstract Effectively responding to global health emergencies requires substantial financial commitment from many stakeholders, including governments, multilateral agencies, and nongovernmental organizations. A major current policy challenge needs attention: how to better coordinate investment among actors aiming to address a common problem, disease outbreaks. For donors who commit colossal sums of money to outbreak response, the current model is neither efficient nor transparent. Innovative approaches to coordinate financing have recently been tested as part of a broader development agenda for humanitarian response. Adopting a system that enables donors to invest in disease outbreaks rather than actors represents an opportunity to deliver a more cost-effective, transparent, and unified global response to infectious disease outbreaks. Achieving this will be challenging, but the World Health Organization (WHO) must play a vital role. New thinking is required to improve emergency response in an increasingly crowded and financially convoluted global health arena.
    MeSH term(s) Disease Outbreaks/economics ; Disease Outbreaks/statistics & numerical data ; Emergency Medical Services/economics ; Emergency Medical Services/statistics & numerical data ; Global Health/economics ; Global Health/statistics & numerical data ; Government Programs/economics ; Government Programs/statistics & numerical data ; Healthcare Financing ; Humans ; International Cooperation
    Keywords covid19
    Language English
    Publishing date 2019-12-03
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 603208-4
    ISSN 1745-655X ; 0197-5897
    ISSN (online) 1745-655X
    ISSN 0197-5897
    DOI 10.1057/s41271-019-00207-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A public health framework for the equitable global allocation of vaccines: COVID-NEEDS.

    Jain, Vageesh / Lorgelly, Paula

    Journal of public health policy

    2022  Volume 43, Issue 1, Page(s) 155–167

    Abstract: The equitable global allocation of COVID-19 vaccines has received much attention yet been poorly defined. Understanding equity requires assessing needs for vaccines across countries. Making distinctions is especially challenging when countries perform ... ...

    Abstract The equitable global allocation of COVID-19 vaccines has received much attention yet been poorly defined. Understanding equity requires assessing needs for vaccines across countries. Making distinctions is especially challenging when countries perform similarly on traditional epidemiological metrics. This Viewpoint offers a novel conceptual framework (COVID-NEEDS) based on empirical evidence and public health guidance. It encompasses health, social, and economic impacts of COVID-19 and associated non-pharmaceutical interventions. We intend this framework to complement existing needs assessment methods to help identify countries most in need of vaccines. We present factors to consider, but future work will be required to understand how to weight the factors and to determine the practical utility of the framework for supplementing existing COVID-19 vaccine allocation mechanisms.
    MeSH term(s) COVID-19/epidemiology ; COVID-19/prevention & control ; COVID-19 Vaccines ; Global Health ; Humans ; Public Health ; SARS-CoV-2 ; Vaccines
    Chemical Substances COVID-19 Vaccines ; Vaccines
    Language English
    Publishing date 2022-01-13
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 603208-4
    ISSN 1745-655X ; 0197-5897
    ISSN (online) 1745-655X
    ISSN 0197-5897
    DOI 10.1057/s41271-021-00325-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The impact of pausing the Oxford-AstraZeneca COVID-19 vaccine on uptake in Europe: a difference-in-differences analysis.

    Jain, Vageesh / Lorgelly, Paula

    European journal of public health

    2022  Volume 32, Issue 4, Page(s) 648–654

    Abstract: Background: Several countries paused their rollouts of the Oxford-AstraZeneca coronavirus disease-19 (COVID-19) vaccine in mid-March 2021 due to concerns about vaccine-induced thrombosis and thrombocytopenia. Many warned that this risked damaging public ...

    Abstract Background: Several countries paused their rollouts of the Oxford-AstraZeneca coronavirus disease-19 (COVID-19) vaccine in mid-March 2021 due to concerns about vaccine-induced thrombosis and thrombocytopenia. Many warned that this risked damaging public confidence during a critical period of pandemic response. This study investigated whether the pause in the use of the Oxford-AstraZeneca vaccine had an impact on subsequent vaccine uptake in European countries.
    Methods: We used a difference-in-differences approach capitalizing on the fact that some countries halted their rollouts whilst others did not. A longitudinal panel was constructed for European Economic Area countries spanning 15 weeks in early 2021. Media reports were used to identify countries that paused the Oxford-AstraZeneca vaccine and the timing of this. Data on vaccine uptake were available through the European Centre for Disease Control and Prevention COVID-19 Vaccine Tracker. Difference-in-differences linear regression models controlled for key confounders that could influence vaccine uptake, and country and week fixed effects. Further models and robustness checks were performed.
    Results: The panel included 28 countries, with 19 in the intervention group and 9 in the control group. Pausing the Oxford-AstraZeneca vaccine was associated with a 0.52% decrease in uptake for the first dose of a COVID-19 vaccine and a 1.49% decrease in the uptake for both doses, comparing countries that paused to those that did not. These estimates are not statistically significant (P = 0.86 and 0.39, respectively). For the Oxford-AstraZeneca vaccine only, the pause was associated with a 0.56% increase in uptake for the first dose and a 0.07% decrease in uptake for both doses. These estimates are also not statistically significant (P = 0.56 and 0.51, respectively). All our findings are robust to sensitivity analyses.
    Conclusions: As new COVID-19 vaccines emerge, regulators should be cautious to deviate from usual protocols if further investigation on clinical or epidemiological grounds is warranted.
    MeSH term(s) COVID-19/epidemiology ; COVID-19/prevention & control ; ChAdOx1 nCoV-19/administration & dosage ; ChAdOx1 nCoV-19/adverse effects ; Europe/epidemiology ; Humans ; Immunization Programs/organization & administration ; Pandemics ; Vaccination/statistics & numerical data
    Chemical Substances ChAdOx1 nCoV-19 (B5S3K2V0G8)
    Language English
    Publishing date 2022-04-17
    Publishing country England
    Document type Journal Article
    ZDB-ID 1129243-x
    ISSN 1464-360X ; 1101-1262
    ISSN (online) 1464-360X
    ISSN 1101-1262
    DOI 10.1093/eurpub/ckac039
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The Real-World Impact of Vaccination on COVID-19 Cases During Europe's Fourth Wave.

    Jain, Vageesh / Serisier, Aimee / Lorgelly, Paula

    International journal of public health

    2022  Volume 67, Page(s) 1604793

    Abstract: Objectives: ...

    Abstract Objectives:
    MeSH term(s) COVID-19/epidemiology ; COVID-19/prevention & control ; Europe/epidemiology ; Humans ; SARS-CoV-2 ; Vaccination
    Language English
    Publishing date 2022-07-05
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2274130-6
    ISSN 1661-8564 ; 1661-8556
    ISSN (online) 1661-8564
    ISSN 1661-8556
    DOI 10.3389/ijph.2022.1604793
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Consensus on disease control objectives in the context of COVID-19 vaccines.

    Jain, Vageesh / Tweed, Sam

    Bulletin of the World Health Organization

    2021  Volume 99, Issue 5, Page(s) 322

    MeSH term(s) COVID-19/prevention & control ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/supply & distribution ; Global Health ; Health Services Accessibility ; Health Services Needs and Demand ; Humans ; Risk Factors ; SARS-CoV-2 ; World Health Organization
    Chemical Substances COVID-19 Vaccines
    Language English
    Publishing date 2021-05-06
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 80213-x
    ISSN 1564-0604 ; 0042-9686 ; 0366-4996 ; 0510-8659
    ISSN (online) 1564-0604
    ISSN 0042-9686 ; 0366-4996 ; 0510-8659
    DOI 10.2471/BLT.20.283846
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Medical research in India and the rise of non-communicable disease.

    Jain, Vageesh

    BMJ (Clinical research ed.)

    2016  Volume 353, Page(s) i3371

    MeSH term(s) Biomedical Research/economics ; Chronic Disease/economics ; Chronic Disease/epidemiology ; Chronic Disease/therapy ; Communicable Diseases/economics ; Financing, Government ; Humans ; India
    Language English
    Publishing date 2016-06-29
    Publishing country England
    Document type Journal Article
    ZDB-ID 1362901-3
    ISSN 1756-1833 ; 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    ISSN (online) 1756-1833
    ISSN 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    DOI 10.1136/bmj.i3371
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Journal ; Article ; Online: Consensus on disease control objectives in the context of COVID-19 vaccines

    Jain, Vageesh / Tweed, Sam

    2021  

    Abstract: ... 322 ... ...

    Abstract 322

    322
    Keywords Editorials
    Language English
    Publisher World Health Organization
    Document type Journal ; Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Measuring the Toll of the COVID-19 Pandemic in Rural Bangladesh.

    Beaney, Thomas / Clarke, Jonathan / Jain, Vageesh

    JAMA network open

    2021  Volume 4, Issue 11, Page(s) e2133167

    MeSH term(s) Bangladesh/epidemiology ; COVID-19 ; Humans ; Pandemics ; Rural Population ; SARS-CoV-2
    Language English
    Publishing date 2021-11-01
    Publishing country United States
    Document type Journal Article ; Comment
    ISSN 2574-3805
    ISSN (online) 2574-3805
    DOI 10.1001/jamanetworkopen.2021.33167
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top